Get the Stockscreener App
0.9702
8.89%
0.0792
After Hours:
1.00
0.0298
+3.07%
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Forecast
The Reviva Pharmaceuticals Holdings Inc (RVPH) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.4903, representing a +156.68% increase from the current price of $0.9702. The highest analyst price target is $2.5803, and the lowest is $2.4003.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RVPH Price Target
Average 1.6258
(+67.57% Upside)
Is Reviva Pharmaceuticals Holdings Inc (RVPH) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.10 | Neutral |
| STOCH(9,6) | 71.45 | Neutral |
| STOCHRSI(14) | 42.51 | Neutral |
| MACD(12,26) | 0.0442 | Buy |
| ADX(14) | 19.69 | Neutral |
| William %R | -45.26 | Neutral |
| CCI(14) | 17.64 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9901
Sell
|
0.9761
Sell
|
| MA20 |
0.9035
Buy
|
0.9331
Buy
|
| MA50 |
0.849
Buy
|
0.9606
Buy
|
| MA100 |
1.2434
Sell
|
1.1127
Sell
|
| MA200 |
1.2783
Sell
|
1.4331
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, RVPH could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on RVPH, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 53.1 indicates that RVPH is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 71.45 indicates that RVPH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 42.51 indicates that RVPH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.69 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 17.64 indicates that RVPH is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term RVPH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Reviva Pharmaceuticals Holdings Inc financial reports and earnings history, Reviva Pharmaceuticals Holdings Inc (RVPH) stock could reach $6.5959 by 2030, $19.42 by 2040 and $14.23 by 2050. See the projected annual prices until 2050 of the Reviva Pharmaceuticals Holdings Inc stock below:
- Reviva Pharmaceuticals Holdings Inc (RVPH) is expected to reach an average price of $3.0422 in 2035, with a high prediction of $3.8721 and a low estimate of $3.2922. This indicates an $213.56% rise from the last recorded price of $0.9702.
- Reviva Pharmaceuticals Holdings Inc (RVPH) stock is projected to chart a bullish course in 2040, with an average price target of $19.74, representing an $1,935% surge from its current level. The forecast ranges from a conservative $19.95 to a sky-high $19.42.
- Our analysts predict Reviva Pharmaceuticals Holdings Inc (RVPH) to jump 2,193% by 2045, soaring from $21.89 to an average price of $22.24, potentially reaching $22.01. While $21.89 is the low estimate, the potential upside is significant.
- Reviva Pharmaceuticals Holdings Inc (RVPH) stock is expected to climb by 2050, reaching an average of $14.81, a $1,426% jump from its current level. However, a wide range of estimates exists, with high and low targets of $14.23 and $14.56, respectively, highlighting the market's uncertainty.
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Year by Year Forecast
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Price Forecast for 2025
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) is expected to reach an average price of $1.5552 in 2025, with a high prediction of $2.5803 and a low estimate of $0.5302. This indicates an +60.30% rise from the last recorded price of $0.9702.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $2.4736 | $2.4003 | $2.5803 | +154.96% |
| August, 2025 | $2.277 | $2.337 | $2.367 | +134.69% |
| September, 2025 | $2.0103 | $2.3824 | $2.257 | +107.21% |
| October, 2025 | $1.967 | $1.727 | $1.827 | +102.74% |
| November, 2025 | $2.2404 | $2.1304 | $2.1904 | +130.92% |
| December, 2025 | $2.7071 | $2.1904 | $2.4771 | +179.02% |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Price Forecast for 2026
The predicted value for Reviva Pharmaceuticals Holdings Inc (RVPH) in 2026 is set at an average of $3.1094. Estimates vary from a peak of $6.2093 to a trough of $0.00948, indicating an +220.49% surge from the present price of $0.9702.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.7004 | $2.7071 | $2.6204 | +178.34% |
| February, 2026 | $3.1289 | $2.8237 | $2.9538 | +222.50% |
| March, 2026 | $1.5171 | $2.2071 | $3.0071 | +56.37% |
| April, 2026 | $2.0338 | $1.5338 | $1.7485 | +109.63% |
| May, 2026 | $0.2428 | $0.5372 | $1.1771 | -74.97% |
| June, 2026 | $1.1695 | $0.2445 | $2.5928 | +20.54% |
| July, 2026 | $0.3428 | $0.00948 | $1.4586 | -64.67% |
| August, 2026 | $1.0495 | $0.1905 | $1.0895 | +8.17% |
| September, 2026 | $1.4428 | $0.8128 | $1.8561 | +48.71% |
| October, 2026 | $1.3794 | $0.8895 | $1.8161 | +42.18% |
| November, 2026 | $1.0661 | $0.3761 | $1.6161 | +9.88% |
| December, 2026 | $5.5094 | $0.9927 | $6.2093 | +467.86% |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Reviva Pharmaceuticals Holdings Inc (RVPH) is $3.4098, with a high forecast of $6.1938 and a low forecast of $0.6258. This indicates an +251.46% increase from the last price of $0.9702.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.136 | $1.956 | $6.1938 | +223.23% |
| February, 2027 | $2.9227 | $2.3927 | $5.0593 | +201.24% |
| March, 2027 | $1.776 | $1.096 | $3.1093 | +83.05% |
| April, 2027 | $1.3726 | $1.121 | $2.0293 | +41.48% |
| May, 2027 | $1.8493 | $0.876 | $2.6093 | +90.61% |
| June, 2027 | $1.9026 | $1.7426 | $3.3759 | +96.10% |
| July, 2027 | $2.3192 | $0.9694 | $4.2426 | +139.05% |
| August, 2027 | $1.3559 | $1.2859 | $3.7927 | +39.75% |
| September, 2027 | $2.7592 | $1.1525 | $3.0492 | +184.39% |
| October, 2027 | $1.5458 | $1.4358 | $3.2959 | +59.33% |
| November, 2027 | $2.0425 | $1.3392 | $2.5725 | +110.52% |
| December, 2027 | $0.9758 | $0.6258 | $2.2592 | +0.58% |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Price Forecast for 2028
In 2028, Reviva Pharmaceuticals Holdings Inc (RVPH) is projected to reach an average price of $3.2381, with a high projection of $5.9636 and a low estimate of $0.5125. This indicates an +233.75% rise from the last price of $0.9702.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.5825 | $0.5125 | $1.9291 | +63.11% |
| February, 2028 | $1.1674 | $0.8258 | $1.5091 | +20.33% |
| March, 2028 | $1.6467 | $1.78 | $1.6267 | +69.73% |
| April, 2028 | $1.7634 | $1.7967 | $1.4844 | +81.76% |
| May, 2028 | $4.3468 | $2.4801 | $2.1018 | +348.03% |
| June, 2028 | $5.7035 | $4.5635 | $5.0335 | +487.87% |
| July, 2028 | $5.1502 | $5.0435 | $5.7402 | +430.84% |
| August, 2028 | $4.9136 | $5.1252 | $4.6636 | +406.45% |
| September, 2028 | $5.1103 | $4.9669 | $4.8903 | +426.72% |
| October, 2028 | $6.127 | $5.6969 | $5.947 | +531.52% |
| November, 2028 | $5.0504 | $5.2204 | $5.9636 | +420.55% |
| December, 2028 | $5.1871 | $5.2671 | $4.8337 | +434.64% |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Price Forecast for 2029
The 2029 price forecast for Reviva Pharmaceuticals Holdings Inc Stock (RVPH) is $6.0522 on average, with a high prediction of $6.8706 and a low estimate of $5.2337. This represents an +523.80% increase from the previous price of $0.9702.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.5704 | $5.2337 | $5.4004 | +474.15% |
| February, 2029 | $5.1671 | $5.3938 | $5.0571 | +432.58% |
| March, 2029 | $5.9238 | $5.4272 | $5.0938 | +510.58% |
| April, 2029 | $6.6505 | $5.9105 | $5.6972 | +585.48% |
| May, 2029 | $6.8039 | $6.8439 | $6.8706 | +601.29% |
| June, 2029 | $6.4806 | $6.5439 | $6.4673 | +567.97% |
| July, 2029 | $5.7873 | $6.1172 | $6.414 | +496.51% |
| August, 2029 | $5.9907 | $5.834 | $5.8917 | +517.47% |
| September, 2029 | $6.2374 | $6.3074 | $6.1807 | +542.90% |
| October, 2029 | $6.6308 | $6.1308 | $6.5108 | +583.45% |
| November, 2029 | $6.6375 | $6.5641 | $6.4575 | +584.14% |
| December, 2029 | $6.8042 | $6.6483 | $6.7642 | +601.32% |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Price Forecast for 2030
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) is expected to reach an average price of $3.3289 in 2030, with a high forecast of $6.5959 and a low forecast of $0.062. This signifies an +243.12% surge from the last price of $0.9702.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.1776 | $5.2076 | $6.5959 | +433.66% |
| February, 2030 | $4.8843 | $5.3442 | $5.3723 | +403.43% |
| March, 2030 | $3.161 | $3.296 | $3.1643 | +225.81% |
| April, 2030 | $2.9677 | $2.2943 | $2.0153 | +205.88% |
| May, 2030 | $3.5311 | $3.3244 | $3.081 | +263.95% |
| June, 2030 | $2.2278 | $2.3878 | $2.4677 | +129.62% |
| July, 2030 | $1.7311 | $1.9978 | $1.8744 | +78.43% |
| August, 2030 | $1.9378 | $1.8212 | $1.5812 | +99.74% |
| September, 2030 | $1.6845 | $2.1145 | $2.0369 | +73.63% |
| October, 2030 | $1.2921 | $0.4446 | $3.1699 | +33.18% |
| November, 2030 | $0.8654 | $0.1554 | $2.2854 | -10.80% |
| December, 2030 | $0.0787 | $0.062 | $2.1187 | -91.89% |
1.89%
3.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):